West Pharma Raises 2024 Profit Forecast Amid Surging Demand for Injectable Therapy Supplies MD Bureau27 Oct 2024 9:45 AM ISTBengaluru: West Pharmaceutical Services raised its annual profit outlook on Thursday after exceeding Wall Street's expectations for quarterly...
Mylan Laboratories Gets CDSCO Nod to Manufacture and Market Epinephrine tartrate Injection Dr. Divya Colin26 Oct 2024 5:45 PM ISTNew Delhi: Mylan Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Johnson & Johnson Gets CDSCO Panel Nod to Study anti-cancer drug Amivantamab Dr. Divya Colin26 Oct 2024 5:30 PM ISTNew Delhi: The drug major Johnson & Johnson has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Philips, Medtronic Ink Advocacy Partnership to Enhance Stroke Care Access Farhat Nasim26 Oct 2024 4:27 PM ISTNetherlands: Royal Philips, a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies,...
Biocon Foundation Wins 2024 Doing Good for Bharat Award in Healthcare for eLAJ Smart Clinics MD Bureau26 Oct 2024 2:38 PM ISTBengaluru: Biocon Foundation, the CSR arm of the Biocon Group of Companies, announced that it has received the esteemed ‘Doing Good for Bharat...
Rhythm Pharma, Axovia Therapeutics Launch Joint Research Collaboration for Bardet-Biedl Syndrome MD Bureau26 Oct 2024 11:00 AM ISTBOSTON: Rhythm Pharmaceuticals, Inc. and Axovia Therapeutics Ltd. have announced a collaborative research effort aimed at advancing insights into...
Merck's KEYTRUDA Gains European Approval for Two New Gynecologic Cancer Treatments MD Bureau25 Oct 2024 5:47 PM ISTWith these approvals, KEYTRUDA is now authorized for 30 indications in the EU, including five in gynecologic cancers, Merck said in a statement.
Bayer, Dewpoint ink USD 424 million deal to develop breakthrough therapy for genetic heart disease MD Bureau25 Oct 2024 3:34 PM ISTBerlin: Bayer has signed an exclusive licensing agreement with Dewpoint Therapeutics, Inc. for a heart disease program targeting patients with...
Marinus Pharma Halts Development After Seizure Drug Fails Trial MD Bureau25 Oct 2024 3:13 PM ISTMarinus said it will discontinue development of the drug, ganaxolone, and take further steps to reduce costs, including job cuts.
Strides Pharma Posts Record Q2 Growth with Rs 12,011 Million Revenue, Highest Ever US Sales MD Bureau25 Oct 2024 3:03 PM ISTBengaluru: Strides Pharma Science Ltd. reported robust Q2FY25 financial results, ending September 30, 2024, with consolidated revenues at Rs 12,011...
Even Healthcare raises Rs 252 crore in Series A funding to launch hospital operations, enhance patient care MD Bureau24 Oct 2024 5:32 PM ISTBengaluru: Even Healthcare, a Bengaluru-based managed care provider, recently secured USD 30 million (approximately Rs 252 crore) in a Series A...
Piramal Pharma Reports Over Fourfold Surge in Q2 Net Profit to Rs 23 Crore, Announces Expansion Plans MD Bureau24 Oct 2024 4:35 PM ISTRevenue from operations rose to Rs 2,242 crore in the second quarter as compared with Rs 1,911 crore in the year-ago period, Piramal Pharma said.
